According to the company, its Phase 1/2 CLARA trial of AURN001 for corneal edema demonstrated significant dose-dependent ...

Camilla Chong, MD, Chief Medical Officer of InflaRx, commented: "We are pleased to have started our Phase 2a trial for INF904 ...

The Clarksburg Water Board hosted its third and final neighborhood outreach meeting Wednesday evening where it informed the ...

A controversial legislation submitted by Prime Minister Narendra Modi’s government to change India’s voting system has failed ...

Viatris Inc. (NASDAQ: VTRS) today announced the publication of Phase 2b CARE study results evaluating the efficacy and safety of cenerimod in adults with moderate-to-severe systemic lupus ...

A drug that combines an atypical antipsychotic and an SSRI is under FDA review, and if approved will be the first ...

This is the last edition of Yield Outlook in 2024. The editorial team wishes our readers a Merry Christmas and a happy and prosperous New Year.

That'll change in a hurry with game seven ... Coincidentally, Arkansas (4-1) starts phase 2 of its schedule against Illinois (3-0) on Thanksgiving Day in Kansas City. Tip is set for 3 p.m ...

Some 90% of investigational drugs fail—and success rates are even more dire in the neuro space. Here, BioSpace looks at five ...

That's about to change with a major redevelopment ... remain open during construction. Phase 1 exhibits are set to debut in the spring of 2025. Phases 2 and 3 will open in the next two to four ...

AnaptysBio's rosnilimab faces significant competition and uncertainty. See why ANAB stock's future hinges on Feb 2025 Phase ...